BioCentury
ARTICLE | Financial News

Collegium raises $22.5M in series B

February 23, 2012 12:50 AM UTC

Collegium Pharmaceutical Inc. (Cumberland, R.I.) raised $22.5 million in a series B round led by Longitude Capital and Skyline Ventures. Existing investors Frazier Healthcare Ventures and Boston Millennia Partners participated. Longitude Capital's David Hirsch and Skyline Ventures' Stephen Hoffman will join Collegium's board. ...